Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza

December 3, 2010 By Bio-Medicine.Org

SEATTLE, Dec. 4, 2010 /PRNewswire-USNewswire/ — The
Infectious Disease Research Institute (IDRI) has been
awarded an $1.8 million contract from the Biomedical Advance
Research and Development Authority (BARDA). IDRI’s work will focus
on development of adjuvant formulations with options up to $8.5
million over three years when further development and manufacture
of priority candidates are approved by the agency.

“BARDA is supporting an important expansion of IDRI’s technology
to solutions that address Neglected Diseases as well as those that
affect us all in the United States,” says Dr. Darrick Carter,
Director of Formulations at IDRI and Principal Investigator on the
BARDA influenza contract. Adjuvants and other immunostimulants can
improve the body’s immune response to diseases like influenza, in
turn, reducing the amount of vaccine needed for protection
(dose-sparing). The use of adjuvants will allow for expansion of
vaccine supply to meet the necessary global demands during a
pandemic.

BARDA is within the U.S. Department of Health and Human Services
Office of the Assistant Secretary for Preparedness and Response.
The project is part of the innovations portfolio awarded out of
BARDA’s Strategic Science and Technology Division’s Innovation BAA
(Broad Agency Announcement).

About IDRI’s Adjuvants

Adjuvants are compounds used to improve the body’s immune
response to vaccines. Adjuvant technology is proving invaluable in
the development of vaccines for serious diseases for which vaccines
are not currently available, including malaria and HIV.

Adjuvants are a key research component of IDRI’s malaria,
tuberculosis, leishmaniasis and leprosy vaccine development
programs — supported by the Bill and Melinda Gates
Foundation, the National Institutes of Health, and the American
Leprosy Missions.

About IDRI – Translating science into global health
solutions

IDRI is a Seattle-based

‘/>”/>

SOURCE

Related Articles Read More >

TE Connectivity opens global medical device prototyping center in Ireland
Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech